- Presentations
- 4
- Markets
- 1
Noxafil is a brand of Posaconazole marketed by Merck Sharp & Dohme, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Posaconazole
- Brand owner
- Merck Sharp & Dohme
- Registered in
- United States
- Strengths and forms
- 300.6 mg/16.7 mL injection, 40 mg/mL oral suspension, 300 mg powder for oral suspension, 100 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Noxafil 300.6 mg/16.7 mL injectionIntravenous Cold chain | Merck Sharp & Dohme | US FDA | Available on request |
| Noxafil 40 mg/mL oral suspensionOral Cold chain | Merck Sharp & Dohme | US FDA | Available on request |
| Noxafil 300 mg powder for oral suspensionOral Cold chain | Merck Sharp & Dohme | US FDA | Available on request |
| Noxafil 100 mg tabletOral Cold chain | Merck Sharp & Dohme | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Noxafil
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.